Portfolio Lab

Cardinal Health Inc

  • Stock
  • Ticker CAH
  • ISIN US14149Y1082
  • NYSE

Health care · Health care services · USA

$272.81 +0.17%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Cardinal Health Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

CAHGlobal equities (VT)

$10,000 grew to $51,112. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −46.1% in 12/2018, measured from the peak in 03/2017. It took 65 months to get back to the old peak.

1-year return
+32.4%
5-year return p.a.
+44.2%
10-year return p.a.
+17.7%
Volatility p.a.
28.3%
Largest decline
−46.1%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end06/202409/202412/202403/202506/202509/202512/202509/2026
Income statement
Revenue59,86752,27755,26454,87860,15964,00965,62767,513
Gross profit1,8821,9021,9412,1232,2022,3192,3972,596
Operating income401568549730428668707753
EBITDA5877507419376379019411,000
Net income235416400506239450467554
Earnings per share0.931.70–––1.88–2.38
Balance sheet
Total assets45,12143,05947,00249,87153,12255,22858,08359,544
Liabilities48,33346,33549,92351,76955,75657,95960,78362,410
Equity-3,213-3,277-2,991-2,948-2,781-2,879-2,884-3,025
Cash5,1332,8673,8103,3263,8744,5932,7775,264
Cash flow
Operating cash flow2,082-1,647-3962,9131,5279736861,398
Capital expenditure-193-90-99-126-232-108-131-157
Free cash flow1,889-1,737-4952,7871,2958655551,241

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +76.3%, weakest 2018 at −24.5%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$2.38
5 Feb 2026–
30 Oct 2025$1.88
12 Aug 2025–
1 May 2025–
30 Jan 2025–
1 Nov 2024$1.70
14 Aug 2024$0.93
2 May 2024$1.07
1 Feb 2024$1.50
3 Nov 2023−$0.05
15 Aug 2023−$0.21

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€57bn
Market cap in trading currency
$63.1bn
Enterprise value
$57.8bn
P/E
–
P/S
–
P/B
–
EV/Sales
–
EV/EBITDA
–
Earnings yield
–
FCF yield
–

Results (last four quarters)

Revenue
–
Gross profit
–
EBITDA
–
Net income
–
Earnings per share
–
Revenue per share
–
Revenue growth
+5.5%
Earnings growth
+23.1%

Profitability

Gross margin
–
Operating margin
–
Net margin
–
Return on equity
–
Return on assets
–

Balance sheet and cash flow

Cash
$5.26bn
Cash per share
$22.77
Financial debt
–
Debt/equity %
–
Current ratio
0.88
Book value per share
−$13.09
Operating cash flow
–
Free cash flow
–

Dividend

Dividend yield
0.75%
Dividend (12 months)
$2.05
Yield (12 months)
0.75%
Payout ratio
–
Ex-dividend date
1 Oct 2026

Shares and trading

Shares outstanding
231m
Volume
1.81m
Avg. volume 3 months
1.71m
Relative volume
1.1

Price and technicals

Price
$272.81
1 day
+0.2%
52-week high
$283.85
52-week low
$182.50
Distance to 52-week high
−3.9%
Distance to 52-week low
+49.5%
Distance to 50-day line
+10.0%
Distance to 200-day line
+20.4%
RSI (14)
61
Volatility 1M
24.8%

Performance

1 week
−2.9%
1 month
+6.7%
3 months
+17.4%
6 months
+35.9%
YTD
+32.8%
1 year
+31.5%

Dates

Fiscal year end
30 Jun 2026
Most recent quarter
30 Sep 2026

Frequently asked questions

How has CAH performed since 11/2016?

$10,000 grew to $51,112 by 20 Nov 2026, which is +17.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is CAH?

Volatility was 28.3% per year, measured on monthly returns. The largest decline from a peak was −46.1%, with the low in 12/2018.

How does CAH compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CAH returned +17.7% at 28.3%. The correlation of monthly returns was 0.37; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Cardinal Health Inc (CAH): Return and risk | Portfolio Lab